- +1-315-215-1633
- sales@thebrainyinsights.com
The global genomics market was valued at USD 30.21 Billion in 2022 and growing at a CAGR of 16.46% from 2023 to 2032. The market is expected to reach USD 138.66 Billion by 2032. Genomics is growing swiftly, and it is a highly dynamic sector. Many factors are driving the market, such as a reduction in the cost of sequencing, a surge in the investment from pharmaceutical organizations and national and international government-funded projects. For instance, in 2012, around 100,000 genome projects were launched by the UK government to sequence 100,000 human genomics. They set up the genomic medicine service for the NHS for the development of new scientific discoveries and to start the development of the genomic industry in the UK. Initially, it focused on rare diseases and cancer and got an investment of around USD 257 Million. Genomics is also used for understanding the more common diseases and conditions like high blood pressure, diabetes and cancer, where genetics helps in the manifestation and progression of such diseases.
Genomics has become the main market from niche. Genomics is now changing the pharma sector and disrupting many business models of payers and providers. It is creating a new market for the next generation of prevention. Precision medicine is growing due to genomics. Precision medicine provides the opportunity to treat the disease more precisely. Genomics has many uses; it is utilized in rare diseases to help the gene discovery of rare diseases and facilitate the development of better diagnostic tools for monogenic disorders. These genomic technologies help clinicians diagnose patients with high-risk genetic errors, which can lead to rare diseases. Many researchers are using genomics to find genes which trigger disease. Single genetics can lead to many diseases; more than 4000 are already identified. Genomics is also used to understand more common diseases and conditions like cancer, diabetes and high blood pressure. Genomics is broadly used in demonstrating and progressing such diseases and conditions. Genomics are very crucial in pharmacogenetics and targeting therapy. Scientists use genetic information to predict patients' responses to a particular drug. It helps doctors in making personalized decisions regarding treatment options. Also, in the treatment of cancer, genomics helps identify genetic drivers for the disease and thus allows for finding a drug which targets the implicated specific pathway. The development of genomics is also benefitting prenatal diagnosis and testing. A genetic disease can be deadly for children; hence prenatal testing is crucial for helping in the decision of early treatment before birth. One of the studies in 2021 found that human genetics and genomics added USD 265 Billion to the US economy in 2019, which is 5 fold increase in around 10 years. The genomics future will mainly be due to the health sector, which is crucial in diagnosing and treating the disease.
Get an overview of this study by requesting a free sample
Growing demand for personalized medication– There is a growing demand for personalized medication with the surge in the repository of personalized data at the molecular level. Personalized medicine is growing rapidly after the Precision Medicine Initiative, announced by Barack Obama in 2015. Also, it has been observed that the cost-efficiency of sequencing has improved, which is a major driver for precision or personalized medicine. Technological, scientific and frontline operation advancements have reduced the cost of deciphering the complete human genome from USD 10,000 in 2011 to USD 1,000 in 2018. Also, some other factors fueling precision medicine are more accurate sequencing, increased targeted therapies, and the heterogeneousness of disease, especially in oncology and rheumatic illnesses. Genomic data is getting used for personalized medicine. All these factors are eventually driving the genomics market.
High Price – Several factors are acting as restraints for the market, like the high prices and shortage of skilled professionals. Skills are needed in bioinformatics and genomics, found in a few professionals. These skills are needed to grow genomics commercially and to improve and enhance the application of genomics. The shortage is restricting potential growth. Also, due to high prices, commercialization and scaling up became key constraints. There is also a very limited number of access points for genetic medicine. For instance, in the US, very few professionals specialize and interact with genes and health, with around 4,700 genetic counsellors and 1,240 medical geneticists certified. All these factors are eventually acting as a restraint for the genomics market.
Mental health treatments – The PGx tests are present in the private market, which offers clinicians data on the drug-gene interactions that help in test-guided prescribing in areas as varied as mental-health, cytotoxic therapy, breast cancer, neurology and pain management, among others. In Australia, there is an investment in PGx-guided drug treatment in mental health. Around USD 7 million were funded by the Australian Government in 2019 for research into using PGx to improve mental health treatment results. It would help in decreasing the suicide cases among patients living with mental health. Other than the PGx application, there are other future potential applications; like in cancer, identifying genetic alterations would direct the health care practitioners towards specific targeted therapies. All these factors are eventually All these factors eventually drive the genomics market in the forecast period.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global genomics market, with a 41.66% share of the market revenue in 2022.
North American region will account for the largest market share with revenue growth. This high market share in North America is attributed to the potential of the US-based firms investing in global genomics revenues. There are many leading pharmaceuticals and research organizations in the US. Also, partnerships are happening among leading organizations in the region. For instance, in January 2022, Illumina Inc. announced its collaboration with Nashville Biosciences, LLC. Asia Pacific is growing at the fastest pace. The surge in the middle class is contributing to the increase in genomics in the region. There is an increase in consumer income along with an increase in awareness and appreciation of health.
North America Region Genomics Market Share in 2022 - 41.66%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The deliverables segment is divided into products and services. The product segment dominated the market, with a market share of around 71.33% in 2022. The genomics market is getting competitive with the launch of many new products. Also, there is a surge in the preference for personalized medicine and a decrease in the costs of DNA sequencing, which brought NGS (Next Generation Sequencing) technology, leading to many novel products.
The application & technology segment is divided into epigenomics, pathway analysis, functional genomics, biomarker discovery and others. The functional genomics segment dominated the market, with a market share of around 40.23% in 2022. This significant market share is due to growing research revealing the controlling of cognitive disease and behaviours using genetic changes. Many more revelations will emerge regarding genetic regulation and its connection with diseases like Autism Spectrum Disorder (ASD). Also, new TGS technologies help explore the genomes, and it is unparallel to any other technologies; hence it is anticipated that TGS will become the new standard in DNA sequencing.
The End User segment is divided into pharmaceutical & biotech companies, academic & Government institutes, hospitals & clinics and others. The pharmaceutical & biotech company segment dominated the market, with a market share of around 48.22% in 2022. It is because pharmaceutical and biotech organizations are investing heavily and trying to change the way healthcare is delivered with better patient lives and improved life expectancy. The key users of applied genomics are pharmaceutical organizations.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 30.21 Billion |
| Market size value in 2032 | USD 138.66 Billion |
| CAGR (2023 to 2032) | 16.46% |
| Historical data | 2019-2021 |
| Base Year | 2022 |
| Forecast | 2023-2032 |
| Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
| Segments | Deliverables, Application & Technology and End User |
North America region emerged as the largest market for the genomics.
The market's growth will be influenced by growing demand for personalized medication.
High price could hamper the market growth.
Mental health treatments will provide huge opportunities to the market.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Deliverables
4.3.2. Market Attractiveness Analysis By Application & Technology
4.3.3. Market Attractiveness Analysis By End User
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Growing demand for personalized medication
5.3. Restraints
5.3.1. High Price
5.4. Opportunities
5.4.1. Mental health treatments
5.5. Challenges
5.5.1. Economic slowdown
6. Global Genomics Market Analysis and Forecast, By Deliverables
6.1. Segment Overview
6.2. Products
6.3. Services
7. Global Genomics Market Analysis and Forecast, By Application & Technology
7.1. Segment Overview
7.2. Epigenomics
7.3. Pathway Analysis
7.4. Functional Genomics
7.5. Biomarker Discovery
7.6. Others
8. Global Genomics Market Analysis and Forecast, By End User
8.1. Segment Overview
8.2. Pharmaceutical & Biotech Company
8.3. Academic & Government Institutes
8.4. Hospital & Clinics
8.5. Others
9. Global Genomics Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Genomics Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Genomics Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Agilent Technologies
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Eppendorf AG
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. QIAGEN N.V.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Color Genomics, Inc.
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Danaher Corporation
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Myriad Genetics, Inc.
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Eurofins Scientific
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. BGI Genomics
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Thermo Fisher Scientific, Inc.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Illumina, Inc.
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. Oxford Nanopore Technologies
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Pacific Biosciences of California, Inc.
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
11.13. Quest Diagnostics Incorporated
11.13.1. Business Overview
11.13.2. Company Snapshot
11.13.3. Company Market Share Analysis
11.13.4. Company Product Portfolio
11.13.5. Recent Developments
11.13.6. SWOT Analysis
11.14. 23andMe, Inc.
11.14.1. Business Overview
11.14.2. Company Snapshot
11.14.3. Company Market Share Analysis
11.14.4. Company Product Portfolio
11.14.5. Recent Developments
11.14.6. SWOT Analysis
11.15. Bio-Rad Laboratories, Inc.
11.15.1. Business Overview
11.15.2. Company Snapshot
11.15.3. Company Market Share Analysis
11.15.4. Company Product Portfolio
11.15.5. Recent Developments
11.15.6. SWOT Analysis
11.16. F. Hoffmann-La Roche Ltd.
11.16.1. Business Overview
11.16.2. Company Snapshot
11.16.3. Company Market Share Analysis
11.16.4. Company Product Portfolio
11.16.5. Recent Developments
11.16.6. SWOT Analysis
11.17. GE Healthcare
11.17.1. Business Overview
11.17.2. Company Snapshot
11.17.3. Company Market Share Analysis
11.17.4. Company Product Portfolio
11.17.5. Recent Developments
11.17.6. SWOT Analysis
List of Table
1. Global Genomics Market, By Deliverables, 2019-2032 (USD Billion)
2. Global Products, Genomics Market, By Region, 2019-2032 (USD Billion)
3. Global Services, Genomics Market, By Region, 2019-2032 (USD Billion)
4. Global Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
5. Global Epigenomics, Genomics Market, By Region, 2019-2032 (USD Billion)
6. Global Pathway Analysis, Genomics Market, By Region, 2019-2032 (USD Billion)
7. Global Functional Genomics, Genomics Market, By Region, 2019-2032 (USD Billion)
8. Global Biomarker Discovery, Genomics Market, By Region, 2019-2032 (USD Billion)
9. Global Others, Genomics Market, By Region, 2019-2032 (USD Billion)
10. Global Genomics Market, By End User, 2019-2032 (USD Billion)
11. Global Pharmaceutical & Biotech Company, Genomics Market, By Region, 2019-2032 (USD Billion)
12. Global Academic & Government Institutes, Genomics Market, By Region, 2019-2032 (USD Billion)
13. Global Hospital & Clinics, Genomics Market, By Region, 2019-2032 (USD Billion)
14. Global Others, Genomics Market, By Region, 2019-2032 (USD Billion)
15. Global Home Care, Genomics Market, By Region, 2019-2032 (USD Billion)
16. North America Genomics Market, By Deliverables, 2019-2032 (USD Billion)
17. North America Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
18. North America Genomics Market, By End User, 2019-2032 (USD Billion)
19. U.S. Genomics Market, By Deliverables, 2019-2032 (USD Billion)
20. U.S. Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
21. U.S. Genomics Market, By End User, 2019-2032 (USD Billion)
22. Canada Genomics Market, By Deliverables, 2019-2032 (USD Billion)
23. Canada Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
24. Canada Genomics Market, By End User, 2019-2032 (USD Billion)
25. Mexico Genomics Market, By Deliverables, 2019-2032 (USD Billion)
26. Mexico Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
27. Mexico Genomics Market, By End User, 2019-2032 (USD Billion)
28. Europe Genomics Market, By Deliverables, 2019-2032 (USD Billion)
29. Europe Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
30. Europe Genomics Market, By End User, 2019-2032 (USD Billion)
31. Germany Genomics Market, By Deliverables, 2019-2032 (USD Billion)
32. Germany Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
33. Germany Genomics Market, By End User, 2019-2032 (USD Billion)
34. France Genomics Market, By Deliverables, 2019-2032 (USD Billion)
35. France Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
36. France Genomics Market, By End User, 2019-2032 (USD Billion)
37. U.K. Genomics Market, By Deliverables, 2019-2032 (USD Billion)
38. U.K. Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
39. U.K. Genomics Market, By End User, 2019-2032 (USD Billion)
40. Italy Genomics Market, By Deliverables, 2019-2032 (USD Billion)
41. Italy Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
42. Italy Genomics Market, By End User, 2019-2032 (USD Billion)
43. Spain Genomics Market, By Deliverables, 2019-2032 (USD Billion)
44. Spain Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
45. Spain Genomics Market, By End User, 2019-2032 (USD Billion)
46. Asia Pacific Genomics Market, By Deliverables, 2019-2032 (USD Billion)
47. Asia Pacific Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
48. Asia Pacific Genomics Market, By End User, 2019-2032 (USD Billion)
49. Japan Genomics Market, By Deliverables, 2019-2032 (USD Billion)
50. Japan Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
51. Japan Genomics Market, By End User, 2019-2032 (USD Billion)
52. China Genomics Market, By Deliverables, 2019-2032 (USD Billion)
53. China Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
54. China Genomics Market, By End User, 2019-2032 (USD Billion)
55. India Genomics Market, By Deliverables, 2019-2032 (USD Billion)
56. India Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
57. India Genomics Market, By End User, 2019-2032 (USD Billion)
58. South America Genomics Market, By Deliverables, 2019-2032 (USD Billion)
59. South America Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
60. South America Genomics Market, By End User, 2019-2032 (USD Billion)
61. Brazil Genomics Market, By Deliverables, 2019-2032 (USD Billion)
62. Brazil Genomics Market, By End User, 2019-2032 (USD Billion)
63. Brazil Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
64. Middle East and Africa Genomics Market, By Deliverables, 2019-2032 (USD Billion)
65. Middle East and Africa Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
66. Middle East and Africa Genomics Market, By End User, 2019-2032 (USD Billion)
67. UAE Genomics Market, By Deliverables, 2019-2032 (USD Billion)
68. UAE Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
69. UAE Genomics Market, By End User, 2019-2032 (USD Billion)
70. South Africa Genomics Market, By Deliverables, 2019-2032 (USD Billion)
71. South Africa Genomics Market, By Application & Technology, 2019-2032 (USD Billion)
72. South Africa Genomics Market, By End User, 2019-2032 (USD Billion)
List of Figures
1. Global Genomics Market Segmentation
2. Global Genomics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Genomics Market Attractiveness Analysis By Deliverables
9. Global Genomics Market Attractiveness Analysis By Application & Technology
10. Global Genomics Market Attractiveness Analysis By End User
11. Global Genomics Market Attractiveness Analysis By Region
12. Global Genomics Market: Dynamics
13. Global Genomics Market Share By Deliverables (2023 & 2032)
14. Global Genomics Market Share By Application & Technology (2023 & 2032)
15. Global Genomics Market Share By End User (2023 & 2032)
16. Global Genomics Market Share By Regions (2023 & 2032)
17. Global Genomics Market Share By Company (2022)
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global genomics market based on below mentioned segments:
Global Genomics Market by Procedure:
Global Genomics Market by Application & Technology:
Global Genomics Market by End-user:
Global Genomics by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
